Titel	Veröffentlichungsdatum	Sprache	Zitate
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles	2000/11/01	English	226
Developing therapeutic microRNAs for cancer	2011/06/02	English	224
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies	2001/03/01	English	221
Gene Therapy Progress and Prospects: Electroporation and other physical methods	2004/08/05	English	220
Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers	1999/09/01	English	220
Prospects of RNA interference therapy for cancer	2005/12/08	English	219
Clinical gene therapy using recombinant adeno-associated virus vectors	2008/04/17	English	215
Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system	1998/05/01	English	215
Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods	2002/08/13	English	213
Stabilized plasmid-lipid particles: construction and characterization	1999/02/01	English	212
Hydroporation as the mechanism of hydrodynamic delivery	2004/01/15	English	211
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival	2004/08/26	English	210
Gene therapy progress and prospects: synthetic polymer-based systems	2008/06/05	English	210
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals	1999/05/01	English	209
Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA	1997/09/01	English	208
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors	2001/09/01	English	207
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation	2004/01/15	English	206
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy	2003/05/20	English	206
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors	2001/09/01	English	205
siRNA therapeutics: big potential from small RNAs	2004/10/21	English	203
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency	2009/12/03	English	201
Lipoplex size is a major determinant of in vitro lipofection efficiency	1999/04/01	English	200
Gene therapy progress and prospects: adenoviral vectors	2003/06/30	English	200
Muscle-derived stem cells	2002/05/01	English	200
Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production	2005/07/01	English	199
The potential for efficacy of the modified (ICP 34.5−) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study	2002/03/01	English	196
Development of a hypoxia-responsive vector for tumor-specific gene therapy	2000/03/01	English	196
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial	2001/02/01	English	195
Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis	1997/03/01	English	195
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer	2008/04/10	English	195